A patient who was declared brain dead after a botched transplant had his left leg amputated.
Now he’s trying to get his leg back in the air, thanks to a new technology.
A new technology, Plasma Physics, uses plasma particles to create a fluid that can propel the body’s limbs.
The technology, developed at Johns Hopkins University, could be the key to helping patients with the rare disease of paralysis that afflicts more than 1.6 million people worldwide.
“What this is, is a really exciting advancement that will help us make a lot of things happen that will hopefully save people’s lives,” said Dr. Peter T. Schoettle, who has been working with Plasma Physics on a treatment for people with paralyzed limbs.
The goal is to be able to use plasma to propel limbs that are damaged in a way that could potentially lead to a life-threatening amputation.
Plasma Physics is an exciting technology that can move limbs, but it’s also a serious problem for people suffering from spinal cord injuries.
In addition to helping paralyzed patients, Plasma Science could potentially improve the quality of life for those suffering from Parkinson’s disease, spinal muscular atrophy and other neurological conditions.
For patients who are suffering from paralysis or spinal cord injury, plasma is an option because it is relatively inexpensive and available in a wide range of sizes.
A plasma treatment is typically delivered by a blood or tissue-infused injection and has been used for decades in hospitals, but Plasma Physics could be a different way to deliver the medicine.
The new treatment uses an electric field, called plasma energy, to drive the limb.
This creates a plasma pocket that could be used to propel the limb in an arc.
The energy is then sent to the brain, where it is released to the muscles that are affected by the injury.
The energy is sent to other areas of the body where the body can use it to power the muscles.
This process, called re-energizing, works to restore some of the function of damaged limbs, as well as to stabilize the muscles in the affected area, said Schoett.
The technique is relatively new, but researchers at Johns Johns Hopkins are hopeful it could eventually be used in the clinic.
“This is the first time that we have a technology that allows us to deliver plasma to the spinal cord to stimulate muscle recovery,” said Schowel.
“This technology will hopefully allow us to get a lot more of the benefits of this technology out into the clinic.”
In the future, Schoetles hopes Plasma Physics will be used by patients in the United States and elsewhere to deliver drugs that have previously been developed for other conditions, such as HIV and cancer.
Plasma Physics has already been used in humans to treat cancer and the brain.
A treatment similar to Plasma Physics would be able be delivered by attaching the technology to a device that could detect when the patient’s limbs are damaged.
The technology could also be used for people who have spinal cord tumors or nerve damage in the neck or shoulders.
A device could then be inserted into the spinal cords of patients who have paralysis.
“We think that Plasma Physics is going to change the way that we think about the treatment of paralysis,” said T. Scott Pemberton, professor of surgery at Johns’ School of Medicine.